Corteva Inc. Common Stock vs CVS Health Corp — how do they compare? Corteva Inc. Common Stock trades at $13.82 (market cap $9.64B), while CVS Health Corp trades at $86.3 (market cap $112.49B). The key difference: CVS Health Corp is far larger — about 11.7× Corteva Inc. Common Stock's market cap, and Corteva Inc. Common Stock pays the higher dividend (4.98%). Which is the better fit depends on your goals — on Pluang, investors hold Corteva Inc. Common Stock for 0 Days and CVS Health Corp for 83 Days on average.
| CTVA | CVS | |
|---|---|---|
Market Cap | $9.64B | $112.49B |
Volume | 41,241,255 | 8,467,392 |
Sector | Basic Materials | Health |
52-Week High | $90.51 | $110.60 |
52-Week Low | $11.92 | $70.08 |
Typical Hold Time | 0 Days | 83 Days |
Enterprise Value | $12.15B | $174.83B |
Dividend Yield | 4.98% | 3.02% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
CVS Health trades at $87.80, up 1.59% today, with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 27% upside. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.58 surpassing the $1.87 estimate. Revenue growth remains solid, reaching $402.07B in 2025, though net margins compressed to 1.18%. The technical picture shows bullish momentum with current price near key support at $87.
CVS presents a compelling value opportunity with attractive valuation multiples (P/E 23.21, P/S 0.27) and dividend stability, but faces margin pressure from healthcare cost trends. The stock's upside depends on maintaining earnings momentum amid reimbursement challenges and regulatory scrutiny highlighted in recent legal investigations.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Corteva provides seeds, crop protection products, and digital tools for agriculture. Its products are used by farmers to manage crop production and protect yields.
Read more on CTVA →Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →